Perspectives for the use of structural information and chemical genetics to develop inhibitors of Janus kinases
Authors:
Open Access
- 1 March 2010
- journal article
- review article
- Published by Wiley in Journal of Cellular and Molecular Medicine
- Vol. 14 (3) , 504-527
Abstract
Introduction Structure/function: the potential interest of the Jak domains as drug targets The growing family of ATP‐competitive nanomolar Jak inhibitors Analogue‐sensitive kinases and possible applications to Jaks Structure‐based interpretation of the Jak mutations Perspectives Gain‐of‐function mutations in the genes encoding Janus kinases have been discovered in various haematologic diseases. Jaks are composed of a FERM domain, an SH2 domain, a pseudokinase domain and a kinase domain, and a complex interplay of the Jak domains is involved in regulation of catalytic activity and association to cytokine receptors. Most activating mutations are found in the pseudokinase domain. Here we present recently discovered mutations in the context of our structural models of the respective domains. We describe two structural hotspots in the pseudokinase domain of Jak2 that seem to be associated either to myeloproliferation or to lymphoblastic leukaemia, pointing at the involvement of distinct signalling complexes in these disease settings. The different domains of Jaks are discussed as potential drug targets. We present currently available inhibitors targeting Jaks and indicate structural differences in the kinase domains of the different Jaks that may be exploited in the development of specific inhibitors. Moreover, we discuss recent chemical genetic approaches which can be applied to Jaks to better understand the role of these kinases in their biological settings and as drug targets.Keywords
This publication has 267 references indexed in Scilit:
- The JAK2 Inhibitor AZD1480 Potently Blocks Stat3 Signaling and Oncogenesis in Solid TumorsCancer Cell, 2009
- Selectivity and therapeutic inhibition of kinases: to be or not to be?Nature Immunology, 2009
- Structure of the Pseudokinase VRK3 Reveals a Degraded Catalytic Site, a Highly Conserved Kinase Fold, and a Putative Regulatory Binding SiteStructure, 2009
- The unfolded protein response signals through high-order assembly of Ire1Nature, 2008
- TrkB kinase is required for recovery, but not loss, of cortical responses following monocular deprivationNature Neuroscience, 2008
- Phenotypic variations and new mutations in JAK2 V617F–negative polycythemia vera, erythrocytosis, and idiopathic myelofibrosisExperimental Hematology, 2007
- A semisynthetic epitope for kinase substratesNature Methods, 2007
- An Allosteric Mechanism for Activation of the Kinase Domain of Epidermal Growth Factor ReceptorCell, 2006
- A unique clonal JAK2 mutation leading to constitutive signalling causes polycythaemia veraNature, 2005
- Mutations of the BRAF gene in human cancerNature, 2002